Related references
Note: Only part of the references are listed.A novel steroidal inhibitor of estrogen-related receptor α (ERRα)
Sarah J. Duellman et al.
BIOCHEMICAL PHARMACOLOGY (2010)
ERβ Impedes Prostate Cancer EMT by Destabilizing HIF-1α and Inhibiting VEGF-Mediated Snail Nuclear Localization: Implications for Gleason Grading
Paul Mak et al.
CANCER CELL (2010)
Safety, Tolerability and Pharmacokinetics of TAS-108, a Novel Anti-Oestrogen, in Healthy Post-Menopausal Japanese Women: A Phase I Single Oral Dose Study
Yuji Kumagai et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2009)
Green tea catechins inhibit angiogenesis through suppression of STAT3 activation
Hoyee Leong et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Growth Inhibition and Regression of Lung Tumors by Silibinin: Modulation of Angiogenesis by Macrophage-Associated Cytokines and Nuclear Factor-kappa B and Signal Transducers and Activators of Transcription 3
Alpna Tyagi et al.
CANCER PREVENTION RESEARCH (2009)
Silibinin Suppresses Growth of Human Prostate Carcinoma PC-3 Orthotopic Xenograft via Activation of Extracellular Signal-Regulated Kinase 1/2 and Inhibition of Signal Transducers and Activators of Transcription Signaling
Rana R. Singh et al.
CLINICAL CANCER RESEARCH (2009)
Regulation of cancer cell metabolism by hypoxia-inducible factor 1
Gregg L. Semenza
SEMINARS IN CANCER BIOLOGY (2009)
ENMD-1198, a novel tubulin-binding agent reduces HIF-1alpha and STAT3 activity in human hepatocellular carcinoma(HCC) cells, and inhibits growth and vascularization in vivo
Christian Moser et al.
BMC CANCER (2008)
Activated STAT3 is a mediator and biomarker of VEGF endothelial activation
Shao-Hua Chen et al.
CANCER BIOLOGY & THERAPY (2008)
STAT3 as a target for inducing apoptosis in solid and hematological tumors
Khandaker Al Zaid Siddiquee et al.
CELL RESEARCH (2008)
Loss of protein inhibitors of activated STAT-3 expression in glioblastoma multiforme tumors: Implications for STAT-3 activation and gene expression
Emily C. Brantley et al.
CLINICAL CANCER RESEARCH (2008)
Role of Stat3 in suppressing anti-tumor immunity
Marcin Kortylewski et al.
CURRENT OPINION IN IMMUNOLOGY (2008)
Transcriptional Control of Energy Homeostasis by the Estrogen-Related Receptors
Vincent Giguere
ENDOCRINE REVIEWS (2008)
Different estrogen receptor β expression in distinct histologic subtypes of lung adenocarcinoma
Greta Ali et al.
HUMAN PATHOLOGY (2008)
Antioestrogen-mediated cell cycle arrest and apoptosis induction in breast cancer and multiple myeloma cells
Jack-Michel Renoir et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2008)
Signal transducer and activator of transcription 3 is required for hypoxia-inducible factor-1α RNA expression in both tumor cells and tumor-associated myeloid cells
Guilian Niu et al.
MOLECULAR CANCER RESEARCH (2008)
Significant antitumor activity in vivo following treatment with the microtubule agent ENMD-1198
Theresa M. LaVallee et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Oestrogen receptor beta over expression in maces with non-small cell lung cancer is associated with better survival
Birgit Guldhammer Skov et al.
LUNG CANCER (2008)
An orally delivered small-molecule formulation with antiangiogenic and anticancer activity
Ofra Benny et al.
NATURE BIOTECHNOLOGY (2008)
STAT3: A critical transcription activator in angiogenesis
Zhong Chen et al.
MEDICINAL RESEARCH REVIEWS (2008)
Involvement of estrogen-related receptors in transcriptional response to hypoxia and growth of solid tumors
Ada Ao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Rationally designed inhibitors identify STAT3 N-domain as a promising anticancer drug target
Olga A. Timofeeva et al.
ACS CHEMICAL BIOLOGY (2007)
Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas
Sizhi Paul Gao et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Vasculogenesis, angiogenesis, and arteriogenesis: Mechanisms of blood vessel formation and remodeling
Gregg L. Semenza
JOURNAL OF CELLULAR BIOCHEMISTRY (2007)
The relevance of estrogen receptor-β expression to the antiproliferative effects observed with histone deacetylase inhibitors and phytoestrogens in prostate cancer treatment
Mark Stettner et al.
MOLECULAR CANCER THERAPEUTICS (2007)
STAT-mediated EGFR signaling in cancer
Kelly M. Quesnelle et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2007)
Estrogenic or antiestrogenic therapies for multiple myeloma?
Brigitte Sola et al.
MOLECULAR CANCER (2007)
Caffeic acid and its synthetic derivative CADPE suppress tumor angiogenesis by blocking STAT3-mediated VEGF expression in human renal carcinoma cells
Joo Eun Jung et al.
CARCINOGENESIS (2007)
Erlotinib in non-small cell lung cancer treatment: Current status and future development
Cesare Gridelli et al.
ONCOLOGIST (2007)
Antiangiogenesis to treat cancer and intraocular neovascular disorders
Farbod Shojaei et al.
LABORATORY INVESTIGATION (2007)
Orientation of endothelial cell division is regulated by VEGF signaling during blood vessel formation
Gefei Zeng et al.
BLOOD (2007)
Estrogen receptor signaling pathways in human non-small cell lung cancer
Diana C. Marquez-Garban et al.
STEROIDS (2007)
Estrogen receptor beta (ERbeta) and inhibition of prostate cancer cell proliferation: Studies on the possible mechanism of action in DU145 cells
A. Pravettoni et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2007)
Estrogen receptor-beta: Recent lessons from in vivo studies
Heather A. Harris
MOLECULAR ENDOCRINOLOGY (2007)
Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network
Angie L. Bookout et al.
CELL (2006)
Antiestrogenic therapies in solid cancers and multiple myeloma
Brigitte Sola et al.
CURRENT MOLECULAR MEDICINE (2006)
Hypoxia-inducible factor-1 in human breast and prostate cancer
K. S. Kimbro et al.
ENDOCRINE-RELATED CANCER (2006)
The metal-responsive transcription factor-1 contributes to HIF-1 activation during hypoxic stress
BJ Murphy et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Role of nuclear receptors in lung tumourigenesis
RA Nemenoff et al.
EUROPEAN JOURNAL OF CANCER (2005)
Angiogenic and cell survival functions of Vascular Endothelial Growth Factor (VEGF)
AM Byrne et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2005)
Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways
Q Xu et al.
ONCOGENE (2005)
Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy
N Ferrara et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
VEGF-targeted therapy: Therapeutic potential and recent advances
LS Rosen
ONCOLOGIST (2005)
Inhibition of vessel permeability by TNP-470 and its polymer conjugate, caplostatin
R Satchi-Fainaro et al.
CANCER CELL (2005)
Estrogen receptor β in prostate cancer
O Imamov et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Dynamic regulation of estrogen receptor-β expression by DNA methylation during prostate cancer development and metastasis
XG Zhu et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Metastases of prostate cancer express estrogen receptor-beta
JS Lai et al.
UROLOGY (2004)
Nuclear translocation of phosphorylated STAT3 is essential for vascular endothelial growth factor-induced human dermal microvascular endothelial cell migration and tube formation
Y Yahata et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Dietary glycine inhibits angiogenesis during wound healing and tumor growth
K Amin et al.
CANCER BIOLOGY & THERAPY (2003)
Effects of TNP-470 on proliferation and apoptosis in human colon cancer xenografts in nude mice
ZH Huang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2003)
Signal transduction by vascular endothelial growth factor receptors
L Claesson-Welsh
BIOCHEMICAL SOCIETY TRANSACTIONS (2003)
Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis
GL Niu et al.
ONCOGENE (2002)
Constitutive activation of Stat3α in brain tumors:: localization to tumor endothelial cells and activation by the endothelial tyrosine kinase receptor (VEGFR-2)
LK Schaefer et al.
ONCOGENE (2002)
Molecular perspectives on selective estrogen receptor modulators (SERMs): progress in understanding their tissue-specific agonist and antagonist actions
DM Lonard et al.
STEROIDS (2002)
Expression, function, and clinical implications of the estrogen receptor β in human lung cancers
Y Omoto et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
VEGF receptor signaling and endothelial function
S Kliche et al.
IUBMB LIFE (2001)
Tumor hypoxia:: Definitions and current clinical, biologic, and molecular aspects
M Höckel et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Vascular-specific growth factors and blood vessel formation
GD Yancopoulos et al.
NATURE (2000)
A peptide derived from the nonreceptor binding region of urokinase plasminogen activator (uPA) inhibits tumor progression and angiogenesis and induces tumor cell death in vivo
YJ Guo et al.
FASEB JOURNAL (2000)
The role of STATs in transcriptional control and their impact on cellular function
J Bromberg et al.
ONCOGENE (2000)
Share Paper
